Page last updated: 2024-10-30

mesalamine and Uveitis, Anterior

mesalamine has been researched along with Uveitis, Anterior in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Uveitis, Anterior: Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Smatlik, N1
Mortada, N1
Röcken, M1
Yazdi, AS1
Zierhut, M1
Lin, Z1
Zhu, B1
Jin, X1

Other Studies

2 other studies available for mesalamine and Uveitis, Anterior

ArticleYear
Mesalazine Suppresses Proinflammatory Cytokines in Patients with Acute Anterior Uveitis Independently of HLA-B27.
    Ocular immunology and inflammation, 2022, Volume: 30, Issue:6

    Topics: Acute Disease; Cytokines; HLA-B27 Antigen; Humans; Mesalamine; Uveitis, Anterior

2022
Onset of HLA-B27-associated diseases in diabetic patient during a period of religious fasting: A case report.
    Medicine, 2018, Volume: 97, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diabetes Mellitus; Diagnostic Techniqu

2018